Precision Medicine for Retinal Disease
Vinit Mahajan is Associate Professor, vitreoretinal surgeon and scientist in the Department of Ophthalmology at Stanford University. He directs the NIH-funded Omics Laboratory that uses high-throughput methods in genomics, proteomics, and phenomics to identify molecules involved in vitreoretinal disease. His research team discovered the first gene to cause non syndromic uveitis and is now using protein crystallography to design therapeutic inhibitors for calpain-5. Prof Mahajan and his team also performed the first CRISPR gene editing therapy for eye disease in human stem cells.
Date:
18 September 2017, 17:00 (Monday, -2nd week, Michaelmas 2017)
Venue:
John Radcliffe West Wing and Children's Hospital, Headington OX3 9DU
Venue Details:
Seminar Room B, Level 6
Speaker:
Vinit B. Mahajan (Stanford University)
Organising department:
Nuffield Department of Clinical Neurosciences
Organiser:
Harry Orlans (University of Oxford)
Organiser contact email address:
harry.orlans@eye.ox.ac.uk
Part of:
Nuffield Department of Clinical Neurosciences
Topics:
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Jacqueline Pumphrey
